文献速递妇科

卵巢癌症状、诊断路径与生存——英国卵巢癌筛查协作试验(UKCTOCS)「不筛查」组人群队列研究

Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
PubMed 文献 · Gynecol Oncol · 2020-06-17

在UKCTOCS不筛查对照组101299名绝经后女性中,574例经结局复核确诊为浸润性上皮性输卵管卵巢癌。出现NICE指南症状或改良Goff指数症状者生存显著更差,每增加一个首发症状死亡风险升高。多因素分析中腹痛与食欲减退/饱胀感与死亡率升高显著相关。

要点

  • 出现NICE指南所列症状者生存显著更差(HR 1.48,95%CI 1.16-1.89,p=0.001)。
  • 出现改良Goff指数症状者生存显著更差(HR 1.68,95%CI 1.32-2.13,p<0.0001)。
  • 每增加一个首发症状,生存下降(HR 1.20,95%CI 1.12-1.28,p<0.0001)。

核心结论

  • 卵巢癌症状指数可识别预后较差的绝经后女性。
  • 本研究不能排除对症状有认识并采取行动者结局更好的可能性。

研究设计与样本

  • 基于UKCTOCS不筛查(对照)组的人群队列研究,纳入101299名女性。
  • 2001年至2005年随机化至2014年12月31日期间,574例经结局复核确诊为浸润性上皮性输卵管卵巢癌。
  • 数据取自病历与电子记录,拟合多变量模型分析症状、症状出现至诊断时间间隔、诊断路径、专科、形态学类型、诊断年龄、诊断年份(时期效应)、分期、主要治疗及残留病灶。

主要发现

  • 出现NICE指南所列症状者较未出现者生存显著更差(HR 1.48,95%CI 1.16-1.89,p=0.001)。
  • 出现改良Goff指数症状者较未出现者生存显著更差(HR 1.68,95%CI 1.32-2.13,p<0.0001)。
  • 每增加一个首发症状,生存下降(HR 1.20,95%CI 1.12-1.28,p<0.0001)。
  • 多因素分析中,除晚期分期、残留病灶增加和主要治疗不充分外,腹痛与食欲减退/饱胀感与死亡率升高显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本研究不能排除对症状有认识并采取行动者结局更好的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There are widespread efforts to increase symptom awareness of 'pelvic/abdominal pain, increased abdominal size/bloating, difficulty eating/feeling full and urinary frequency/urgency' in an attempt to diagnose ovarian cancer earlier. Long-term survival of women with these symptoms adjusted for known prognostic factors is yet to be determined. This study explored the association of symptoms, routes and interval to diagnosis and long-term survival in a population-based cohort of postmenopausal women diagnosed with invasive epithelial tubo-ovarian cancer (iEOC) in the 'no screen' (control) UKCTOCS arm. METHODS: Of 101,299 women in the control arm, 574 were confirmed on outcome review to have iEOC between randomisation (2001-2005) and 31 December 2014. Data was extracted from medical notes and electronic records. A multivariable model was fitted for individual symptoms, time interval from symptom onset to diagnosis, route to diagnosis, speciality, morphological Type, age at diagnosis, year of diagnosis (period effect), stage, primary treatment, and residual disease. RESULTS: Women presenting with symptoms listed in the NICE guidelines (HR1.48, 95%CI1.16-1.89, p = 0.001) or the modified Goff Index (HR1·68, 95%CI1·32-2.13, p < 0.0001) had significantly worse survival than those who did not. Each additional presenting symptom decreased survival (HR1·20, 95%CI1·12-1·28, p < 0.0001). In multivariable analysis, in addition to advanced stage, increasing residual disease and inadequate primary treatment, abdominal pain and loss of appetite/feeling full were significantly associated with increased mortality. CONCLUSIONS: The ovarian cancer symptom indices identify postmenopausal women with a poorer prognosis. This study however cannot exclude the possibility of better outcomes in those who are aware and act on their symptoms.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Dilley J, Burnell M, Gentry-Maharaj A, et al. Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Gynecol Oncol. 2020. PMID: 32561125. doi:10.1016/j.ygyno.2020.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。